These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39188784)

  • 1. [Continuous glucose monitoring devices in people over 65 years: literature review].
    Guisado-Barral B; Chacón-Vargas KA; Andrés-Rodríguez NF; Fornos-Pérez JA; Mera-Gallego R; Busto-Domínguez I; Mera-Gallego I; León-Rodríguez L
    Farm Comunitarios; 2024 Jul; 16(3):29-42. PubMed ID: 39188784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review.
    Gómez-Peralta F; Leiva-Gea I; Duque N; Artime E; Rubio de Santos M
    Adv Ther; 2024 Sep; 41(9):3471-3488. PubMed ID: 39093492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Uhl S; Choure A; Rouse B; Loblack A; Reaven P
    J Clin Endocrinol Metab; 2024 Mar; 109(4):1119-1131. PubMed ID: 37987208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemia according to the Use of Continuous Glucose Monitoring among Adults with Type 1 Diabetes Mellitus in Korea: A Real-World Study.
    Lee YB; Kim M; Kim JH
    Diabetes Metab J; 2023 May; 47(3):405-414. PubMed ID: 36872066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review on clinical implication of continuous glucose monitoring in diabetes management.
    Azhar A; Gillani SW; Mohiuddin G; Majeed RA
    J Pharm Bioallied Sci; 2020; 12(2):102-111. PubMed ID: 32742108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Teo E; Hassan N; Tam W; Koh S
    Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
    Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
    Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring in Older Adults: What We Know and What We Have Yet to Learn.
    Price C; Callahan KE; Aloi JA; Usoh CO
    J Diabetes Sci Technol; 2024 May; 18(3):577-583. PubMed ID: 38454549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
    Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
    Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation.
    Joshi S; Verma R; Lathia T; Selvan C; Tanna S; Saraf A; Tiwaskar M; Modi A; Kalra S; K V; Chitale M; Malde F; Abdul Khader M; Singal AK
    JMIR Diabetes; 2023 May; 8():e43292. PubMed ID: 37133922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.